Certificate of Pharmaceutical Product for Algeria

Using an FDA COPP to Register Medicines in Algeria

A Certificate of a Pharmaceutical Product (COPP) is the document that regulators worldwide rely on when a medicine made in one country is registered in another. It follows the format of the World Health Organization Certification Scheme. In the U.S. it is issued by the FDA’s Center for Drug Evaluation and Research (CDER). It tells the importing regulator whether the product is approved and marketed in the United States, who holds the approval, and whether the manufacturing site is subject to inspection under good manufacturing practice.

The COPP in an ANPP dossier

In Algeria, medicines are registered with the National Agency for Pharmaceutical Products (ANPP). For a U.S.-made product, the COPP is a core document in the registration dossier, alongside the product’s technical file, and it is often requested again for renewals and variations. Algerian pharmaceutical importers and distributors also ask for it when they take on a new U.S. product. Because the ANPP reviews the COPP against the rest of the dossier, the product name, strength, dosage form, applicant and manufacturing sites must match exactly.

Requesting the COPP for Algeria

Apply to CDER naming Algeria as the importing country, and describe the product exactly as it appears in the Algerian file. If the product is not marketed in the U.S., the COPP will say so, and the ANPP may then ask for an explanation or additional evidence, so discuss this with your regulatory team first. Order as many originals as you have dossiers. Every registration, renewal or distributor file typically needs its own apostilled original.

Apostille by the U.S. Department of State

The COPP bears the signature of an FDA official, which makes it a federal document. No notary touches it and no state office reviews it. The original is presented as issued to the federal Office of Authentications at the Department of State, which attaches the apostille. Since Algeria’s accession to the Apostille Convention took effect on July 9, 2026, that apostille is all the ANPP needs as proof of authenticity. The Algerian Embassy step has ended.

Active ingredients and other FDA certificates

For medical devices, foods, supplements and cosmetics, the matching FDA document is the Certificate to Foreign Government, not a COPP. Products made only for export use a Certificate of Exportability. Each follows the same federal apostille route for Algeria.

Planning the timeline

Registration timelines in Algeria are long, and an expired or rejected certificate can set a dossier back months. Ask your Algerian agent how recent the COPP must be at submission, apply to the FDA accordingly, and send the certificates for apostille as soon as they arrive.